Skip Navigation
Skip to contents

PHRP : Osong Public Health and Research Perspectives

OPEN ACCESS
SEARCH
Search

Articles

Page Path
HOME > Osong Public Health Res Perspect > Volume 11(2); 2020 > Article
Short Communication Coronavirus Disease-19: The First 7,755 Cases in the Republic of Korea
Osong Public Health and Research Perspectives 2020;11(2):85-90.
DOI: https://doi.org/10.24171/j.phrp.2020.11.2.05
Published online: March 31, 2020
  • 17,963 Views
  • 675 Download
  • 76 Crossref
  • 82 Scopus

Korea Centers for Disease Control and Prevention, Cheongju, Korea

*Corresponding author: COVID-19 National Emergency Response Center, Epidemiology and Case Management Team, Korea Centers for Disease Control and Prevention, Cheongju, Korea, E-mail: jeongek@korea.kr
• Received: March 13, 2020   • Revised: March 19, 2020   • Accepted: March 20, 2020

Copyright ©2020, Korea Centers for Disease Control and Prevention

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

This article has been corrected. See "Corrigendum to “Coronavirus Disease-19: The First 7,755 Cases in the Republic of Korea” [Osong Public Health Res Perspect 2020;11(2):85–90]" in Volume 11 on page 146.
  • We report the first 7,755 patients with confirmed COVID-19 in Korea as of March 12th, 2020. A total of 66 deaths have been recorded, giving a case fatality proportion of 0.9%. Older people, and those with comorbidities were at a higher risk of a fatal outcome. The highest number of cases of COVID-19 were in Daegu, followed by Gyeongbuk. This summary may help to understand the disease dynamics in the early phase of the COVID-19 outbreaks, and may therefore, guide future public health measures.
Only a few weeks after the first case of coronavirus disease 2019 (COVID-19) was reported in Wuhan, China, the first case of COVID-19 was confirmed in the Republic of Korea on January 20th, 2020 [1]. International travel has facilitated the spread of COVID-19 throughout the world. As of March 13th, 2020, 118 countries, territories, and areas have reported COVID-19 cases, however, differences in patterns and intensity of transmission ranges were observed [2]. In February and early March in Korea, a sharp increase in the number of COVID-19 cases were observed, with most infections in specific clusters and geographical regions.
Based on the surveillance data, we report the basic epidemiological characteristics of COVID-19 to examine the early course of the pandemic. Furthermore, factors associated with COVID-19 cases and fatality were investigated to provide information on a vulnerable part of the population to guide public health prioritization.
This is a summary of the first 7,755 patients with confirmed COVID-19 in Korea as of March 12th, 2020. To obtain demographic, epidemiological, and early clinical information, COVID-19 reporting and surveillance data were retrieved from Korea Centers for Disease Control and Prevention (KCDC)-operated National Notifiable Disease Surveillance System (NNDSS) [3]. The patient age was provided on the date of diagnosis, and key indicators such as estimated duration of exposure, date of onset of symptoms, and route of transmission were identified by field epidemiological investigators [1]. It must be noted that the data presented in this summary may change depending on the results of further epidemiological investigations.
As of March 12th, 2020, a total of 7,755 laboratory-confirmed cases of COVID-19 and 66 deaths were recorded in Korea, giving a case fatality proportion of 0.9% (Table 1). The female-to-male ratio of confirmed COVID-19 cases was 62:38. The age group 20–29 years accounted for the highest level of all confirmed cases at 28.9%, followed by 50–59 years, and 40–49 years. The case fatality proportion was 0.1% among 30–39 years and 40–49 years age groups, then increased to 0.4% in the 50–59 years, 1.5% in the 60–69 years, 5.0% in the 70–79 years, and 8.5% in the ≥80 years age groups (Table 1).
The epidemic curves presented in Figures 1 and 2 were generated using National Notifiable Disease Surveillance System (NNDSS) data. Epidemic curves by date of onset preceded epidemic curves by date of diagnosis, by a few days or a week (Figure 1). It must be noted that the date of symptom onset may change depending on further epidemiological investigation, and delayed reporting of cases. Figure 2 depicts an epidemic curve by different regions of Korea: the nationwide, Daegu, Gyeongbuk, and others (outside Daegu and Gyeongbuk). From mid-February, an increased number of cases were reported with a peak in late February and early March. Figure 3 shows the age distribution and sex ratio among Daegu, Gyeongbuk, and others regions. Note the increased proportion of cases in 20–29 years and in females among cases in Daegu and Gyeongbuk.
Fatal cases of COVID-19 in Korea, as of March 12th, 2020 are shown in Tables 2 and 3. Case fatality proportion was the highest among people aged ≥ 80 years in Daegu, followed by those aged 70–79 years in Daegu, and elderly persons ≥ 80 years old in Gyeongbuk. Overall case fatality proportion in Daegu and Gyeongbuk were 0.8% and 1.4%, which were higher than that in other regions with 0.4%. Figure 4 depicts age-specific epidemic curve stratified as 0–59 years and ≥ 60 years. The outbreak generally began with the younger age group, followed by the elderly population.
There were 66 laboratory-confirmed fatal cases of COVID-19, as of March 12th, 2020 (Table 3). The median age was 77 years (range, 35–93 years), and female-to-male ratio of 44:56. Of 63 cases, 96.8% were reported to have comorbidities: 47.6% hypertension, 36.5% diabetes, 16% neurodegenerative disorders, and 17.5% pulmonary diseases. There were 71.2% of fatal cases in Daegu and 24.2% were from Gyeongbuk. There were 5 patients who succumbed to death at home, and COVID-19 was identified as the cause of death in 11 individuals after their death. The median interval between onset of symptoms and death was 10 days (range 1–24 days), while the median interval between date of hospitalization and date of death was 5 days (range 0–16 days).
The analysis of the first 7,755 cases of COVID-19 in Korea showed an initial increase in cases in specific geographical regions, comparable to the epidemiological situation in China and Italy [4,5]. In Korea, despite a sharp decline in the number of confirmed cases reported, there were still a relevant number of confirmed cases per week in late February and early March. With descriptive analysis of interim surveillance data, the data suggest that the patient outcome differed markedly between the geographic regions, highlighting the magnitude of surge of cases and access to hospitalization. The difference in age distribution of COVID-19 cases compared with China may reflect active surveillance of a cluster of religious groups tied to the outbreak.
A summary of the epidemiological characteristics of the first 7,755 COVID-19 cases in Korea confirms the contagiousness of COVID-19 that led to a nationwide outbreak in a few weeks. Triaging patients for hospitalization, social distancing (to reduce the number of contacts), and reporting the outbreak amongst vulnerable people in the population may have played a role in the recent decline in cases of COVID-19. However, in the initial response to COVID-19, quarantine, early detection, and isolation of suspected cases of COVID-19, may have contributed to lowering the wave of this epidemic in other parts of Korea. More severe cases were reported in the elderly with existing comorbidities, which warrants clear triage management and a high-risk approach in healthcare access prioritization. COVID-19 does not appear to be fatal among young adults and children, however their role in disease transmission should be further assessed.
This summary may help in the understanding of early phase disease dynamics for the COVID-19 outbreak, and guide future public health measures in other countries.
We thank the relevant ministries, including the Ministry of Interior and Safety, Si/Do and Si/Gun/Gu, medical staffs in health centers, and medical facilities for their efforts in responding to the COVID-19 outbreak.

Conflicts of Interest

The authors have no conflicts of interest to declare.

COVID-19 National Emergency Response Center, Epidemiology and Case Management Team

Korea Centers for Disease Control and Prevention (KCDC):

Eun Kyeong Jeong

Center for Disease Prevention, KCDC: Ok Park, Young Joon Park, Shin Young Park, Young-Man Kim, Jieun Kim, Joongho Jo, Jungwoo Kim, Taeyoung Kim, Sanghui Kweon, Yeonhee Woo, Minwoo Yum, Eunyoung Kim

Center for Public Health Emergency Preparedness and Response, KCDC: Jin Gwack, Jin Lee, Eunmi Park, Seong Sun Kim, Junghee Hyun, Boyeong Ryu, Yoon Suk Jang, Hwami Kim, Yeowon Jin, Hyeyoung Lee, Sangeun Lee, Seung Hwan Shin, Seung Woo Choi, Daehyeon Ko, Seonju Yi, Hee Kyoung Kim

Center for Infectious Disease Control, KCDC: Dongwook Kim, Byoung-Hak Jeon, Miyoung Kim, Si won Choi

Center for Genome Science, KCDC: Jung Hyun Lee, Jae Kyung Park

Bureau of Health Policy, Ministry of Health and Welfare:

Unna Kim

Department of Social and Preventive Medicine, Hallym University College of Medicine: Young June Choe

Figure 1
Epidemic curve of laboratory-confirmed coronavirus disease-19 by date of symptom onset and by date of diagnosis, as of March 7, 2020, Republic of Korea.
Provisional data for date of symptom onset.
ophrp-11-85f1.jpg
Figure 2
Epidemic curve of laboratory-confirmed coronavirus disease-19 cases by date of symptom onset, as of March 7, 2020, Republic of Korea.
Provisional data for date of symptom onset.
ophrp-11-85f2.jpg
Figure 3
Age distribution and sex ratio of the first 7,755 cases of laboratory-confirmed coronavirus disease-19, as of March 12 2020, Republic of Korea.
ophrp-11-85f3.jpg
Figure 4
Age-specific epidemic curve of laboratory-confirmed coronavirus disease-19 cases by date of symptom onset, as of March 7, 2020, Republic of Korea.
Provisional data for date of symptom onset.
ophrp-11-85f4.jpg
Table 1
Demographics and case fatality proportion of the first 7,755 laboratory-confirmed COVID-19 cases, as of March 12th 2020, Republic of Korea.
Variables Confirmed cases Deaths CFP



n % n %
Sex
 Female 4,808 (62.0) 25 (0.5)
 Male 2,947 (38.0) 35 (1.2)

Age group (y)
 0–9 75 (1.0) - -
 10–19 405 (5.2) - -
 20–29 2,238 (28.9) - -
 30–39 804 (10.4) 1 (0.1)
 40–49 1,082 (14.0) 1 (0.1)
 50–59 1,472 (19.0) 6 (0.4)
 60–69 960 (12.4) 14 (1.5)
 70–79 483 (6.2) 24 (5.0)
 ≥ 80 236 (3.0) 20 (8.5)

Total 7,755 66 (0.9)

CFP = case fatality proportion.

Table 2
Number of deaths and case fatality proportion for laboratory-confirmed COVID-19 cases by geographic region, as of March 12th 2020, Republic of Korea.
Age group (y) Daegu Gyeongbuk Others



Deaths Total cases CFP Deaths Total cases CFP Deaths Total cases CFP
0–9 - 48 - - 9 - - 18 -

10–19 - 314 - - 43 - - 48 -

20–29 - 1,787 - - 279 - - 173 -

30–39 - 590 - - 76 - 1 137 (0.7)

40–49 - 778 - 1 142 (0.7) - 162 -

50–59 1 1,061 (0.1) 4 260 (1.5) 1 150 (0.7)

60–69 10 719 (1.4) 4 162 (2.5) - 79 -

70–79 21 373 (5.6) 3 69 (4.3) - 42 -

≥ 80 15 124 (12.1) 4 96 (4.2) 1 16 (6.3)

Total 47 5,794 (0.8) 16 1,136 (1.4) 3 825 (0.4)

CFP = case fatality proportion.

Table 3
Fatal cases (n = 66) of laboratory-confirmed COVID -19 cases, as of March 12th 2020, Republic of Korea.
Variables n (%)
Age (y), median (range) 77 (35–93)

Sex
 Female 29 (43.9)
 Male 37 (56.1)

Coexisting condition*
 Any 61 (96.8)
  Cerebrovascular disease 5 (7.9)
  Heart disease 10 (15.9)
  Pulmonary disease 11 (17.5)
  Kidney disease 5 (7.9)
  Diabetes 23 (36.5)
  Hypertension 30 (47.6)
  Cancer 7 (11.1)
  Neurodegenerative disorder 16 (25.4)
 Under investigation 5 (6.5)

Region
 Daegu 47 (71.2)
 Gyeongbuk 16 (24.2)
 Others 3 (4.5)

Death while in home 5 (7.6)
Diagnosis after death 11 (16.7)
Interval, days, median (range)
 Symptom → Death 10 (1–24)
 Symptom → Diagnosis 4 (0–20)
 Symptom → Hospitalization 4.5 (0–11)
 Hospitalization → Death 5 (0–16)
 Total 66

* A single case may have multiple comorbidities (investigation files required).

Figure & Data

References

    Citations

    Citations to this article as recorded by  
    • Prevalence of cancer as a comorbid in COVID-19 patients and their characteristics: a meta-analysis study
      Johan S. Sitanggang, Kamal B. Siregar, Henry H. Sitanggang, Noverita Sprinse Vinolina
      F1000Research.2022; 10: 975.     CrossRef
    • Correction of menopausal disorders: new possibilities of menopausal hormone therapy
      L. Yu. Karakhalis
      Meditsinskiy sovet = Medical Council.2022; (5): 112.     CrossRef
    • On the Parametrization of Epidemiologic Models—Lessons from Modelling COVID-19 Epidemic
      Yuri Kheifetz, Holger Kirsten, Markus Scholz
      Viruses.2022; 14(7): 1468.     CrossRef
    • Clinical Outcomes and Severity of Acute Respiratory Distress Syndrome in 1154 COVID-19 Patients: An Experience Multicenter Retrospective Cohort Study
      Abbas Al Mutair, Saad Alhumaid, Laila Layqah, Jinan Shamou, Gasmelseed Y. Ahmed, Hiba Chagla, Khulud Alsalman, Fadhah Mohammed Alnasser, Koritala Thoyaja, Waad N. Alhuqbani, Mohammed Alghadeer, Mohammed Al Mohaini, Sana Almahmoud, Jaffar A. Al-Tawfiq, Jav
      COVID.2022; 2(8): 1102.     CrossRef
    • Impact of COVID-19 Pandemic on Thyroid Surgery in a University Hospital in South Korea
      Seong Hoon Kim, Euna Min, Young Mi Hwang, Yun Suk Choi, Jin Wook Yi
      Cancers.2022; 14(17): 4338.     CrossRef
    • Prevalence of comorbidities among individuals with COVID-19: A rapid review of current literature
      Kalpana Thapa Bajgain, Sujan Badal, Bishnu B. Bajgain, Maria J. Santana
      American Journal of Infection Control.2021; 49(2): 238.     CrossRef
    • First results of the “Lean European Open Survey on SARS-CoV-2-Infected Patients (LEOSS)”
      Carolin E. M. Jakob, Stefan Borgmann, Fazilet Duygu, Uta Behrends, Martin Hower, Uta Merle, Anette Friedrichs, Lukas Tometten, Frank Hanses, Norma Jung, Siegbert Rieg, Kai Wille, Beate Grüner, Hartwig Klinker, Nicole Gersbacher-Runge, Kerstin Hellwig, Luk
      Infection.2021; 49(1): 63.     CrossRef
    • Angiotensin‐converting enzyme as a new immunologic target for the new SARS‐CoV‐2
      Shahin Hallaj, Anahita Ghorbani, Seyed Ali Mousavi‐Aghdas, Mohammad Mirza‐Aghazadeh‐Attari, Andrey Sevbitov, Vida Hashemi, Tooba Hallaj, Farhad Jadidi‐Niaragh
      Immunology & Cell Biology.2021; 99(2): 192.     CrossRef
    • Cardiovascular diseases burden in COVID-19: Systematic review and meta-analysis
      Amirhossein Hessami, Amir Shamshirian, Keyvan Heydari, Fatemeh Pourali, Reza Alizadeh-Navaei, Mahmood Moosazadeh, Saeed Abrotan, Layla Shojaie, Sogol Sedighi, Danial Shamshirian, Nima Rezaei
      The American Journal of Emergency Medicine.2021; 46: 382.     CrossRef
    • Older Adults With Coronavirus Disease 2019: A Nationwide Study in Turkey
      Mert Esme, Meltem Koca, Ayse Dikmeer, Cafer Balci, Naim Ata, Burcu Balam Dogu, Mustafa Cankurtaran, Meltem Yilmaz, Osman Celik, Gulnihal Gokce Unal, Mustafa Mahir Ulgu, Suayip Birinci, Anne B Newman
      The Journals of Gerontology: Series A.2021; 76(3): e68.     CrossRef
    • Taiwan's COVID-19 response: Timely case detection and quarantine, January to June 2020
      Hao-Yuan Cheng, Yu-Neng Chueh, Chiu-Mei Chen, Shu-Wan Jian, Shu-Kuan Lai, Ding-Ping Liu
      Journal of the Formosan Medical Association.2021; 120(6): 1400.     CrossRef
    • Metabolic Syndrome and COVID-19 Mortality Among Adult Black Patients in New Orleans
      John Xie, Yuanhao Zu, Ala Alkhatib, Thaidan T. Pham, Frances Gill, Albert Jang, Stella Radosta, Gerard Chaaya, Leann Myers, Jerry S. Zifodya, Christine M. Bojanowski, Nassir F. Marrouche, Franck Mauvais-Jarvis, Joshua L. Denson
      Diabetes Care.2021; 44(1): 188.     CrossRef
    • Epidemiologic Linkage of COVID-19 Outbreaks at Two University-affiliated Hospitals in the Seoul Metropolitan Area in March 2020
      Kuenyoul Park, Jaewoong Lee, Kihyun Lee, Jiwon Jung, Sung-Han Kim, Jina Lee, Mauricio Chalita, Seok-Hwan Yoon, Jongsik Chun, Kyu-Hwa Hur, Heungsup Sung, Mi-Na Kim, Hae Kyung Lee
      Journal of Korean Medical Science.2021;[Epub]     CrossRef
    • Exploration of sex-specific and age-dependent COVID-19 fatality rate in Bangladesh population
      Md Abdul Alim Al-Bari, Showna Hossain, Md Kudrat-E Zahan
      World Journal of Radiology.2021; 13(1): 1.     CrossRef
    • Coronavirus disease 2019 and neurodegenerative disease: what will the future bring?
      Lindsay S. McAlpine, Arman Fesharaki-Zadeh, Serena Spudich
      Current Opinion in Psychiatry.2021; 34(2): 177.     CrossRef
    • Network study of responses to unusualness and psychological stress during the COVID-19 outbreak in Korea
      Seunghyong Ryu, In-Hoo Park, Mina Kim, Yu-Ri Lee, Jonghun Lee, Honey Kim, Min Jhon, Ju-Wan Kim, Ju-Yeon Lee, Jae-Min Kim, Sung-Wan Kim, Akihiro Nishi
      PLOS ONE.2021; 16(2): e0246894.     CrossRef
    • Factors Influencing the Preventive Practice of International Students in South Korea against COVID-19 during the Pandemic
      Gun Ja Jang, Ginam Jang, Sangjin Ko
      International Journal of Environmental Research an.2021; 18(5): 2259.     CrossRef
    • Epidemiology, clinical spectrum, viral kinetics and impact of COVID ‐19 in the Asia‐Pacific region
      Kin On Kwok, Ying Huang, Margaret Ting Fong Tsoi, Arthur Tang, Samuel Yeung Shan Wong, Wan In Wei, David Shu Cheong Hui
      Respirology.2021; 26(4): 322.     CrossRef
    • Clinical Reviews of COVID-19 for Otorhinolaryngologists
      Ki-Il Lee, Dong Kyu Kim, Ji-Hun Mo
      Journal of Rhinology.2021; 28(1): 1.     CrossRef
    • Validation of the Korean Version of the COVID-19 Phobia Scale (K-C19PS)
      Mihyeon Seong, Misoon Lee, Insook Kim, Miran Kang
      International Journal of Environmental Research an.2021; 18(7): 3747.     CrossRef
    • Risk Assessment of Importation and Local Transmission of COVID-19 in South Korea: Statistical Modeling Approach
      Hyojung Lee, Yeahwon Kim, Eunsu Kim, Sunmi ‍Lee
      JMIR Public Health and Surveillance.2021; 7(6): e26784.     CrossRef
    • Impact of obesity on the health of men and women during the COVID-19 pandemic
      L.V. Adamyan, E.N. Andreeva, E.V. Sheremetyeva, G.A. Manushakyan
      Problemy reproduktsii.2021; 27(3): 28.     CrossRef
    • SARS-CoV-2 Seroprevalence and Neutralizing Antibody Response after the First and Second COVID-19 Pandemic Wave in Croatia
      Tatjana Vilibic-Cavlek, Vladimir Stevanovic, Maja Ilic, Ljubo Barbic, Krunoslav Capak, Irena Tabain, Jasna Lenicek Krleza, Thomas Ferenc, Zeljka Hruskar, Renata Zrinski Topic, Vanja Kaliterna, Arlen Antolovic-Pozgain, Jasmina Kucinar, Iva Koscak, Dijana M
      Pathogens.2021; 10(6): 774.     CrossRef
    • Clinical Features and Outcomes of Coronavirus Disease 2019 Among People With Human Immunodeficiency Virus in the United States: A Multicenter Study From a Large Global Health Research Network (TriNetX)
      George A Yendewa, Jaime Abraham Perez, Kayla Schlick, Heather Tribout, Grace A McComsey
      Open Forum Infectious Diseases.2021;[Epub]     CrossRef
    • The first 1000 symptomatic pediatric SARS-CoV-2 infections in an integrated health care system: a prospective cohort study
      Leigh M. Howard, Kathryn Garguilo, Jessica Gillon, Kerry LeBlanc, Adam C. Seegmiller, Jonathan E. Schmitz, Daniel W. Byrne, Henry J. Domenico, Ryan P. Moore, Steven A. Webber, Natasha B. Halasa, Ritu Banerjee
      BMC Pediatrics.2021;[Epub]     CrossRef
    • Prevalence and characteristics of cancer patients with COVID-19: a meta-analysis study
      Johan S. Sitanggang, Kamal B. Siregar, Henry H. Sitanggang, Noverita Sprinse Vinolina
      F1000Research.2021; 10: 975.     CrossRef
    • Factors shaping the COVID-19 epidemic curve: a multi-country analysis
      Su Yeon Jang, Laith Hussain-Alkhateeb, Tatiana Rivera Ramirez, Ahmed Asa’ad Al-Aghbari, Dhia Joseph Chackalackal, Rocio Cardenas-Sanchez, Maria Angelica Carrillo, In-Hwan Oh, Eduardo Andrés Alfonso-Sierra, Pia Oechsner, Brian Kibiwott Kirui, Martin Anto,
      BMC Infectious Diseases.2021;[Epub]     CrossRef
    • Experience from five Asia-Pacific countries during the first wave of the COVID-19 pandemic: Mitigation strategies and epidemiology outcomes
      Clotilde El Guerche-Séblain, Lina Chakir, Gopinath Nageshwaran, Rebecca C. Harris, Caroline Sevoz-Couche, Olivier Vitoux, Philippe Vanhems
      Travel Medicine and Infectious Disease.2021; 44: 102171.     CrossRef
    • Policy Review and Modeling Analysis of Mitigation Measures for Coronavirus Disease Epidemic Control, Health System, and Disease Burden, South Korea
      Hae-Young Kim, In-Hwan Oh, Jacob Lee, Jeong-Yeon Seon, Woo-Hwi Jeon, Jae Seok Park, Sung-Il Nam, Niket Thakkar, Prashanth Selvaraj, Jessica McGillen, Daniel Klein, Scott Braithwaite, Anna Bershteyn, Seung Heon Lee
      Emerging Infectious Diseases.2021;[Epub]     CrossRef
    • A Review on the Role of Stem Cells against SARS-CoV-2 in Children and Pregnant Women
      Fatemeh Sanie-Jahromi, Yaser NejatyJahromy, Rahim Raoofi Jahromi
      International Journal of Molecular Sciences.2021; 22(21): 11787.     CrossRef
    • COVID-19 Vaccination in Pregnancy, Paediatrics, Immunocompromised Patients, and Persons with History of Allergy or Prior SARS-CoV-2 Infection: Overview of Current Recommendations and Pre- and Post-Marketing Evidence for Vaccine Efficacy and Safety
      Nicoletta Luxi, Alexia Giovanazzi, Annalisa Capuano, Salvatore Crisafulli, Paola Maria Cutroneo, Maria Pia Fantini, Carmen Ferrajolo, Ugo Moretti, Elisabetta Poluzzi, Emanuel Raschi, Claudia Ravaldi, Chiara Reno, Marco Tuccori, Alfredo Vannacci, Giovanna
      Drug Safety.2021; 44(12): 1247.     CrossRef
    • Therapeutic opportunities for improving the course of coronavirus disease and reducing the frequency of gestional complications
      V.V. Kaminskyi, R.O. Tkachenko, A.V. Kaminskyi, O.I. Zhdanovych, L.I. Vorobei, T.V. Kolomiichenko, O.I. Gervaziuk, R.R. Tkachuk, S.I. Mudryi
      REPRODUCTIVE ENDOCRINOLOGY.2021; (62): 8.     CrossRef
    • The Outbreak of COVID-19 and Diabetes in Korea: “We Will Find a Way as We Have Always Done”
      Kyu Chang Won, Kun Ho Yoon
      Diabetes & Metabolism Journal.2020; 44(2): 211.     CrossRef
    • Transmission dynamics, serial interval and epidemiology of COVID-19 diseases in Hong Kong under different control measures
      Yung-Wai Desmond Chan, Stefan Flasche, Tin-Long Terence Lam, Mei-Hung Joanna Leung, Miu-Ling Wong, Ho-Yeung Lam, Shuk-Kwan Chuang
      Wellcome Open Research.2020; 5: 91.     CrossRef
    • Clinical Course of Asymptomatic and Mild COVID-19: Early Clinical Features of Patients Admitted to a Living and Treatment Support Center in Jecheon, South Korea (Part II)
      Soomin Nam, Yeon Ho Lee, Se Hwan An, Eun Hee Kim, So Hee Hong, Jeon Wook Kwon, Seung Wook Lee, Hyoung Seop Kim
      SSRN Electronic Journal .2020;[Epub]     CrossRef
    • Clinical Course of COVID-19 in Asymptomatic and Mildly Symptomatic Patients: Archives of a Living and Treatment Support Center in South Korea (Part I)
      Soomin Nam, Yeon Ho Lee, Kye Seon Jang, Mun Young Chang, Do Hyeon Yun, Hye Seon Park, Jin Kyu Lee, Hyoung Seop Kim
      SSRN Electronic Journal .2020;[Epub]     CrossRef
    • Surveillance of the first cases of COVID-19 in Sergipe using a prospective spatiotemporal analysis: the spatial dispersion and its public health implications
      Lucas Almeida Andrade, Dharliton Soares Gomes, Marco Aurélio de Oliveira Góes, Mércia Simone Feitosa de Souza, Daniela Cabral Pizzi Teixeira, Caíque Jordan Nunes Ribeiro, José Antônio Barreto Alves, Karina Conceição Gomes Machado de Araújo, Allan Dantas d
      Revista da Sociedade Brasileira de Medicina Tropic.2020;[Epub]     CrossRef
    • Evaluation of COVID-19 epidemic outbreak caused by temporal contact-increase in South Korea
      Sungchan Kim, Yong Dam Jeong, Jong Hyuk Byun, Giphil Cho, Anna Park, Jae Hun Jung, Yunil Roh, Sooyoun Choi, Ibrahim Malik Muhammad, Il Hyo Jung
      International Journal of Infectious Diseases.2020; 96: 454.     CrossRef
    • Children in the Eye of the Pandemic Storm—Lessons From New York City
      Jason G. Newland, Kristina A. Bryant
      JAMA Pediatrics.2020; 174(10): e202438.     CrossRef
    • COVID-19 and the re-opening of schools: a policy maker’s dilemma
      Maria Pia Fantini, Chiara Reno, Giovanni Battista Biserni, Elena Savoia, Marcello Lanari
      Italian Journal of Pediatrics.2020;[Epub]     CrossRef
    • Easing lockdown for school children: why so contentious?
      Amelia Swift
      Evidence Based Nursing.2020; 23(3): 65.     CrossRef
    • Children are unlikely to be the main drivers of the COVID‐19 pandemic – A systematic review
      Jonas F. Ludvigsson
      Acta Paediatrica.2020; 109(8): 1525.     CrossRef
    • Diabetes as a risk factor for greater COVID-19 severity and in-hospital death: A meta-analysis of observational studies
      Alessandro Mantovani, Christopher D. Byrne, Ming-Hua Zheng, Giovanni Targher
      Nutrition, Metabolism and Cardiovascular Diseases.2020; 30(8): 1236.     CrossRef
    • Prevalence of comorbidities in patients and mortality cases affected by SARS-CoV2: a systematic review and meta-analysis
      Omar Ariel Espinosa, Andernice dos Santos Zanetti, Ednardo Fornanciari Antunes, Fabiana Gulin Longhi, Tatiane Amorim de Matos, Paula Franciene Battaglini
      Revista do Instituto de Medicina Tropical de São P.2020;[Epub]     CrossRef
    • SARS‐CoV ‐2 testing and outcomes in the first 30 days after the first case of COVID ‐19 at an Australian children's hospital
      Laila F Ibrahim, Shidan Tosif, Sarah McNab, Samantha Hall, Hyun Jung Lee, Stuart Lewena, Andrew J Daley, Nigel W Crawford, Andrew C Steer, Penelope A Bryant, Franz E Babl
      Emergency Medicine Australasia.2020; 32(5): 801.     CrossRef
    • The Epidemiology of Severe Acute Respiratory Syndrome Coronavirus 2 in a Pediatric Healthcare Network in the United States
      William R Otto, Sarah Geoghegan, Leila C Posch, Louis M Bell, Susan E Coffin, Julia S Sammons, Rebecca M Harris, Audrey R Odom John, Xianqun Luan, Jeffrey S Gerber
      Journal of the Pediatric Infectious Diseases Socie.2020; 9(5): 523.     CrossRef
    • The role of children in transmission of SARS-CoV-2: A rapid review
      Xue Li, Wei Xu, Marshall Dozier, Yazhou He, Amir Kirolos, Evropi Theodoratou
      Journal of Global Health.2020;[Epub]     CrossRef
    • Improving Preparedness for and Response to Coronavirus Disease 19 (COVID-19) in Long-Term Care Hospitals in Korea
      Tark Kim
      Infection & Chemotherapy.2020; 52(2): 133.     CrossRef
    • Encountering COVID-19 as Endocrinologists
      Eun-Jung Rhee, Jung Hee Kim, Sun Joon Moon, Won-Young Lee
      Endocrinology and Metabolism.2020; 35(2): 197.     CrossRef
    • Coronavirus Disease 2019 and Diabetes: The Epidemic and the Korean Diabetes Association Perspective
      Junghyun Noh, Hyun-Ha Chang, In-Kyung Jeong, Kun Ho Yoon
      Diabetes & Metabolism Journal.2020; 44(3): 372.     CrossRef
    • Covid-19: a comprehensive review of a formidable foe and the road ahead
      Arafat Hussain, Suniti Yadav, Vijay Hadda, Tejas M Suri, Pawan Tiwari, Saurabh Mittal, Karan Madan, Anant Mohan
      Expert Review of Respiratory Medicine.2020; 14(9): 869.     CrossRef
    • COVID‐19 breakthroughs: separating fact from fiction
      Paraminder Dhillon, Manuel Breuer, Natasha Hirst
      The FEBS Journal.2020; 287(17): 3612.     CrossRef
    • The Mental Health and Sleep Quality of the Medical Staff at a Hub-Hospital against COVID-19 in South Korea
      Doo Hyuk Kwon, Jihye Hwang, Yong Won Cho, Mei Ling Song, Keun Tae Kim
      Journal of Sleep Medicine.2020; 17(1): 93.     CrossRef
    • Diabetes and COVID-19: Global and regional perspectives
      In-Kyung Jeong, Kun Ho Yoon, Moon Kyu Lee
      Diabetes Research and Clinical Practice.2020; 166: 108303.     CrossRef
    • Epidemiology of COVID-19 and Predictors of Recovery in the Republic of Korea
      Ashis Kumar Das, Saji Saraswathy Gopalan
      Pulmonary Medicine.2020; 2020: 1.     CrossRef
    • Clinical characteristics, laboratory outcome characteristics, comorbidities, and complications of related COVID-19 deceased: a systematic review and meta-analysis
      Peishan Qiu, Yunjiao Zhou, Fan Wang, Haizhou Wang, Meng Zhang, Xingfei Pan, Qiu Zhao, Jing Liu
      Aging Clinical and Experimental Research.2020; 32(9): 1869.     CrossRef
    • The Clinical Characteristics and Outcomes of Patients with Moderate-to-Severe Coronavirus Disease 2019 Infection and Diabetes in Daegu, South Korea
      Mi Kyung Kim, Jae-Han Jeon, Sung-Woo Kim, Jun Sung Moon, Nan Hee Cho, Eugene Han, Ji Hong You, Ji Yeon Lee, Miri Hyun, Jae Seok Park, Yong Shik Kwon, Yeon-Kyung Choi, Ki Tae Kwon, Shin Yup Lee, Eon Ju Jeon, Jin-Woo Kim, Hyo-Lim Hong, Hyun Hee Kwon, Chi Yo
      Diabetes & Metabolism Journal.2020; 44(4): 602.     CrossRef
    • Rapid Deployment of a Free, Privacy-Assured COVID-19 Symptom Tracker for Public Safety During Reopening: System Development and Feasibility Study
      Seble G Kassaye, Amanda Blair Spence, Edwin Lau, David M Bridgeland, John Cederholm, Spiros Dimolitsas, JC Smart
      JMIR Public Health and Surveillance.2020; 6(3): e19399.     CrossRef
    • Comorbidities and the risk of severe or fatal outcomes associated with coronavirus disease 2019: A systematic review and meta-analysis
      Yue Zhou, Qing Yang, Jingwei Chi, Bingzi Dong, Wenshan Lv, Liyan Shen, Yangang Wang
      International Journal of Infectious Diseases.2020; 99: 47.     CrossRef
    • Quantification of Death Risk in Relation to Sex, Pre-Existing Cardiovascular Diseases and Risk Factors in COVID-19 Patients: Let’s Take Stock and See Where We Are
      Amalia Ioanna Moula, Linda Renata Micali, Francesco Matteucci, Fabiana Lucà, Carmelo Massimiliano Rao, Orlando Parise, Gianmarco Parise, Michele Massimo Gulizia, Sandro Gelsomino
      Journal of Clinical Medicine.2020; 9(9): 2685.     CrossRef
    • Estradiol, Progesterone, Immunomodulation, and COVID-19 Outcomes
      Franck Mauvais-Jarvis, Sabra L Klein, Ellis R Levin
      Endocrinology.2020;[Epub]     CrossRef
    • Aging, Male Sex, Obesity, and Metabolic Inflammation Create the Perfect Storm for COVID-19
      Franck Mauvais-Jarvis
      Diabetes.2020; 69(9): 1857.     CrossRef
    • Evolutionary and structural analyses of SARS-CoV-2 D614G spike protein mutation now documented worldwide
      Sandra Isabel, Lucía Graña-Miraglia, Jahir M. Gutierrez, Cedoljub Bundalovic-Torma, Helen E. Groves, Marc R. Isabel, AliReza Eshaghi, Samir N. Patel, Jonathan B. Gubbay, Tomi Poutanen, David S. Guttman, Susan M. Poutanen
      Scientific Reports.2020;[Epub]     CrossRef
    • Endocrine Significance of SARS-CoV-2’s Reliance on ACE2
      Eric Lazartigues, Mirza Muhammad Fahd Qadir, Franck Mauvais-Jarvis
      Endocrinology.2020;[Epub]     CrossRef
    • Epidemiologic, clinical, and laboratory findings of the COVID-19 in the current pandemic: systematic review and meta-analysis
      Yewei Xie, Zaisheng Wang, Huipeng Liao, Gifty Marley, Dan Wu, Weiming Tang
      BMC Infectious Diseases.2020;[Epub]     CrossRef
    • First-time Diabetic Ketoacidosis in Type 2 Diabetics With Covid-19 Infection: A Novel Case Series
      Alexander Croft, Antonino Bucca, Jaclyn H. Jansen, Christine Motzkus, Audrey Herbert, Alfred Wang, Benton R. Hunter
      The Journal of Emergency Medicine.2020; 59(5): e193.     CrossRef
    • Can data from paediatric cohorts solve the COVID-19 puzzle?
      Lien Anh Ha Do, Jeremy Anderson, Edward Kim Mulholland, Paul V. Licciardi, Carolyn B. Coyne
      PLOS Pathogens.2020; 16(9): e1008798.     CrossRef
    • On the Progression of COVID-19 in Portugal: A Comparative Analysis of Active Cases Using Non-linear Regression
      Ana Milhinhos, Pedro M. Costa
      Frontiers in Public Health.2020;[Epub]     CrossRef
    • Clinical Features and Outcome of SARS-CoV-2 Infection in Children: A Systematic Review and Meta-analysis
      Jitendra Meena, Jaivinder Yadav, Lokesh Saini, Arushi Yadav, Jogender Kumar
      Indian Pediatrics.2020; 57(9): 820.     CrossRef
    • Fasting Plasma Glucose Level Independently Predicts the Mortality of Patients with Coronavirus Disease 2019 Infection: A Multicenter, Retrospective Cohort Study
      Min Cheol Chang, Jong-Moon Hwang, Jae-Han Jeon, Sang Gyu Kwak, Donghwi Park, Jun Sung Moon
      Endocrinology and Metabolism.2020; 35(3): 595.     CrossRef
    • Adaptive Feature Selection Guided Deep Forest for COVID-19 Classification With Chest CT
      Liang Sun, Zhanhao Mo, Fuhua Yan, Liming Xia, Fei Shan, Zhongxiang Ding, Bin Song, Wanchun Gao, Wei Shao, Feng Shi, Huan Yuan, Huiting Jiang, Dijia Wu, Ying Wei, Yaozong Gao, He Sui, Daoqiang Zhang, Dinggang Shen
      IEEE Journal of Biomedical and Health Informatics.2020; 24(10): 2798.     CrossRef
    • Delay-adjusted age- and sex-specific case fatality rates for COVID-19 in South Korea: Evolution in the estimated risk of mortality throughout the epidemic
      A.T. Newall, R.N.F. Leong, A. Nazareno, D.J. Muscatello, J.G. Wood, W.J. Kim
      International Journal of Infectious Diseases.2020; 101: 306.     CrossRef
    • Transmission dynamics, serial interval and epidemiology of COVID-19 diseases in Hong Kong under different control measures
      Yung-Wai Desmond Chan, Stefan Flasche, Tin-Long Terence Lam, Mei-Hung Joanna Leung, Miu-Ling Wong, Ho-Yeung Lam, Shuk-Kwan Chuang
      Wellcome Open Research.2020; 5: 91.     CrossRef
    • Intensive Care Unit Capacity and Its Associated Risk Factors During the COVID-19 Surge in the Republic of Korea: Analysis Using Nationwide Health Claims Data


      Seung Heon Lee, So-Youn Park, Jeong-Yeon Seon, Woo-Hwi Jeon, Sung Il Nam, Jong-Hak Park, Jae Seok Park, Hae-Young Kim, Niket Thakkar, Prashanth Selvaraj, Anna Bershteyn, In-Hwan Oh
      Risk Management and Healthcare Policy.2020; Volume 13: 2571.     CrossRef
    • Clinical Features of COVID-19 in Uzbekistan
      KyungHee Kim, Jae Wook Choi, Juyoung Moon, Habibulla Akilov, Laziz Tuychiev, Bakhodir Rakhimov, Kwang Sung Min
      Journal of Korean Medical Science.2020;[Epub]     CrossRef
    • COVID-19 gender susceptibility and outcomes: A systematic review
      Ines Lakbar, David Luque-Paz, Jean-Louis Mege, Sharon Einav, Marc Leone, Andrea Cortegiani
      PLOS ONE.2020; 15(11): e0241827.     CrossRef

    Figure
    Related articles

    PHRP : Osong Public Health and Research Perspectives